Evaluation of safety, efficacy and immunogenicity of a recombinant FVIII molecule

We propose a meta-analytic project which aims at summarizing Post-Authorization Surveillance Safety data on Advate, a recombinant FVIII concentrates used to treat patients with Hemophilia A. The study will involve the largest cohort of hemophilia patients on FVIII concentrates analyzed in the literature. The project represents an attempt to sustain a methodologically strong approach in […]

Read More